Robin Sherrington insider trades
Robin Sherrington has filed 7 Form 4s with the SEC that we hold, all for Xenon Pharmaceuticals Inc. (XENE), as EVP, Strategy & Innovation. Across all of them we count 0 purchases worth $0 and 9 sales worth $3.5M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 35,103 shares of Xenon Pharmaceuticals Inc. worth $1.3M, dated 2022-09-01. The first filing on our record is dated 2022-03-08 and the latest 2024-03-12.
Xenon Pharmaceuticals Inc. (XENE)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-03-04 | S, sale reported on Form 4 | 5,000 | $151.2K | 2022-03-08 |
| 2022-03-04 | S, sale reported on Form 4 | 5,000 | $150.8K | 2022-03-08 |
| 2022-03-04 | S, sale reported on Form 4 | 5,000 | $155.2K | 2022-03-08 |
| 2022-03-04 | S, sale reported on Form 4 | 6,710 | $205.1K | 2022-03-08 |
| 2022-08-31 | S, sale reported on Form 4 | 21,352 | $823.5K | 2022-09-02 |
| 2022-09-01 | S, sale reported on Form 4 | 8,776 | $340.5K | 2022-09-02 |
| 2022-09-01 | S, sale reported on Form 4 | 35,103 | $1.3M | 2022-09-02 |
| 2024-03-07 | S, sale reported on Form 4 | 6,118 | $283.3K | 2024-03-08 |
| 2024-03-07 | S, sale reported on Form 4 | 1,019 | $47.0K | 2024-03-08 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1619962) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms